drugset / Trial / NCT00935142
Non-invasive Imaging With [18F]VM4-037
NaSingle-groupOpen-labelDiagnostic
Summary
The purpose of this study is to determine the toxicity of the hypoxia PET-tracer \[18F\]-VM4-037 in cancer patients in two dose-steps: * Step 1 (3-6 patients): a single dose of maximum 8 mCi (296 MBq) dose of \[18F\]VM4-037 via a bolus IV injection. * Step 2 (3-6 patients): a single dose of maximum 12 mCi (444 MBq) dose of \[18F\]VM4-037 via a bolus IV injection
Timeline
- Start
- 2012-01
- Primary completion
- 2012-11
- Completion
- 2012-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | 18F-VM4-037 | Diagnostic / imaging agent | 296 mbq | Intravenous |
| Subject | 18F-VM4-037 | Diagnostic / imaging agent | 444 mbq | Intravenous |
Indications
No indication recorded.